共 752 条
- [1] Larrey D(2002)Epidemiology and individual susceptibility to adverse drug reactions affecting the liver Semin Liver Dis 22 145-155
- [2] Verma S(2009)Diagnosis, management and prevention of drug-induced liver injury Gut. 58 1555-1564
- [3] Kaplowitz N(2020)Epidemiology, predisposing factors, and outcomes of drug-induced liver injury Clin Liver Dis 24 1-10
- [4] Bjornsson ES(2019)Incidence and etiology of drug-induced liver injury in mainland China Gastroenterology. 156 2230-2241
- [5] Shen T(2017)Current limitations and future opportunities for prediction of DILI from in vitro Arch Toxicol 91 131-142
- [6] Liu Y(2014)ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury Am J Gastroenterol 109 950-966
- [7] Shang J(2019)EASL Clinical Practice Guidelines: drug-induced liver injury J Hepatol 70 1222-1261
- [8] Xie Q(2017)CSH guidelines for the diagnosis and treatment of drug-induced liver injury Hepatol Int 11 221-241
- [9] Li J(2017)Transcriptional, functional, and mechanistic comparisons of stem cell-derived hepatocytes, HepaRG cells, and three-dimensional human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury Drug Metab Dispos 45 419-429
- [10] Yan M(2010)General review on in vitro hepatocyte models and their applications Methods Mol Biol 640 1-40